4//SEC Filing
HOROWITZ ZEBULUN D 4
Accession 0001230295-07-000157
CIK 0000722104other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:49 PM ET
Size
7.6 KB
Accession
0001230295-07-000157
Insider Transaction Report
Form 4
HOROWITZ ZEBULUN D
SVP - Chief Medical Officer
Transactions
- Award
Common Stock, $.01 par value per share
2007-03-05$12.51/sh+41,500$519,165→ 161,871 total - Sale
Common Stock, $.01 par value per share
2007-03-05$12.50/sh−18,942$236,775→ 142,929 total
Footnotes (3)
- [F1]The right to receive these shares is pursuant to a performance based restricted stock grant, a portion of which vested on March 5, 2007.
- [F2]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of performance based restricted stock granted on February 15, 2005.
- [F3]Represents the average sale price. The highest price at which shares were sold was $12.50 and the lowest price at which shares were sold was $12.491.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001225436
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:49 PM ET
- Size
- 7.6 KB